Growth Metrics

Corcept Therapeutics (CORT) Change in Acquisitions & Divestments (2017 - 2025)

Corcept Therapeutics (CORT) has disclosed Change in Acquisitions & Divestments for 10 consecutive years, with $132.0 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 64.37% to $132.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $389.6 million through Dec 2025, down 5.64% year-over-year, with the annual reading at $389.6 million for FY2025, 5.64% down from the prior year.
  • Change in Acquisitions & Divestments hit $132.0 million in Q4 2025 for Corcept Therapeutics, up from $52.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $207.5 million in Q1 2023 to a low of -$258.4 million in Q4 2021.
  • Historically, Change in Acquisitions & Divestments has averaged $75.7 million across 5 years, with a median of $79.9 million in 2022.
  • Biggest five-year swings in Change in Acquisitions & Divestments: surged 392.5% in 2023 and later crashed 71.23% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at -$258.4 million in 2021, then skyrocketed by 130.74% to $79.4 million in 2022, then plummeted by 40.83% to $47.0 million in 2023, then soared by 70.92% to $80.3 million in 2024, then surged by 64.37% to $132.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for CORT at $132.0 million in Q4 2025, $52.0 million in Q3 2025, and $93.5 million in Q2 2025.